Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rink

Showing results (181-190 of 292) with videos related to

Pageof 30
Sort By:
Urologic Oncology|August 19, 2014
MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarraysStefan Steurer, Julius Magnus Singer, Michael Rink, et al.
BJU International|June 7, 2014
Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patientsIlaria Lucca, Morgan Rouprêt, Luis Kluth, et al.
European Urology Focus|June 10, 2025
A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder CancerMithun Kailavasan, Alberto Martini, Max Bruins, et al.
Annals of Surgical Oncology|October 27, 2012
Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomyEvanguelos Xylinas, Michael Rink, Giacomo Novara, et al.
The Journal of Urology|December 21, 2012
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomyEvanguelos Xylinas, Michael Rink, Vitaly Margulis, et al.
Clinical Genitourinary Cancer|February 13, 2023
Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical CystectomyMarkus von Deimling, Victor M Schuettfort, David D'Andrea, et al.
European Urology Focus|April 19, 2021
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical CystectomyChiara Lonati, Philipp Baumeister, Paola Irene Ornaghi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 21, 2017
Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective studyRieken Malte, Luis A Kluth, Dharam Kaushik, et al.
World Journal of Urology|June 9, 2023
Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinomaMarkus von Deimling, David D'Andrea, Benjamin Pradere, et al.
European Urology|October 22, 2013
Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over timeGuillaume Ploussard, Shahrokh F Shariat, Alice Dragomir, et al.
Pageof 30

Showing results (181-190 of 292) with videos related to

Sort By:
Pageof 30
Urologic Oncology|August 19, 2014
MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarraysStefan Steurer, Julius Magnus Singer, Michael Rink, et al.
BJU International|June 7, 2014
Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patientsIlaria Lucca, Morgan Rouprêt, Luis Kluth, et al.
European Urology Focus|June 10, 2025
A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder CancerMithun Kailavasan, Alberto Martini, Max Bruins, et al.
Annals of Surgical Oncology|October 27, 2012
Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomyEvanguelos Xylinas, Michael Rink, Giacomo Novara, et al.
The Journal of Urology|December 21, 2012
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomyEvanguelos Xylinas, Michael Rink, Vitaly Margulis, et al.
Clinical Genitourinary Cancer|February 13, 2023
Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical CystectomyMarkus von Deimling, Victor M Schuettfort, David D'Andrea, et al.
European Urology Focus|April 19, 2021
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical CystectomyChiara Lonati, Philipp Baumeister, Paola Irene Ornaghi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 21, 2017
Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective studyRieken Malte, Luis A Kluth, Dharam Kaushik, et al.
World Journal of Urology|June 9, 2023
Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinomaMarkus von Deimling, David D'Andrea, Benjamin Pradere, et al.
European Urology|October 22, 2013
Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over timeGuillaume Ploussard, Shahrokh F Shariat, Alice Dragomir, et al.
Pageof 30